Strona 3 - Najlepsi lekarze wykonujący radioterapię – TOP 99 lekarzy

Dr Amir specjalizuje się w zaawansowanych terapiach raka piersi, w tym radioterapii. Jego badania i metody leczenia są poparte ponad 30 prezentacjami na spotkaniach naukowych.

• Laureat Nagrody ESMO za Badania Translacyjne w Raku Piersi (ESMO Breast Cancer Translational Research Award)
• Ukończył szkolenie stypendialne (fellowship) w zakresie badań nad rakiem piersi na Uniwersytecie Emory
• Członek Europejskiego Towarzystwa Onkologii Klinicznej
• Wielokrotny laureat nagród ISCORT „Najlepsza praca roku”

Profesor nadzwyczajny od 2016 roku, dr Ozatli specjalizuje się w leczeniu raka piersi, płuc oraz nowotworów przewodu pokarmowego w Istinye University Liv Hospital Bahcesehir.

• Specjalista chorób wewnętrznych z doświadczeniem zdobytym w najlepszych tureckich szpitalach
• Doświadczenie w leczeniu złożonych przypadków onkologicznych w zakresie wielu typów nowotworów
• Członek tureckich stowarzyszeń onkologicznych z postępującymi osiągnięciami naukowymi

Dr Auala Hubert kieruje Ośrodkiem Onkologii Przewodu Pokarmowego w Centrum Medycznym Hadassah, mając 33 lata specjalistycznego doświadczenia w onkologii i radioterapii.

• Specjalizuje się w onkologii klinicznej i radioterapii
• Starszy lekarz w Szpitalu Uniwersyteckim Hadassah
• Posiada certyfikat w zakresie onkologii i radioterapii
• Członek Izraelskiego Towarzystwa Onkologii Klinicznej

Dr Alon Pikarsky ma ponad 30 lat doświadczenia chirurgicznego, specjalizując się w chirurgii kolorektalnej w Centrum Medycznym Hadassah.

• Od 1995 roku Instruktor Chirurgii, szkolący przyszłych chirurgów
• Od 1997 roku Dyrektor Programu dla Studentów Medycyny
• Od 1998 roku posiada Certyfikat Izraelskiej Izby Lekarskiej w zakresie Chirurgii Ogólnej
• Od 1998 roku Członek różnych stowarzyszeń chirurgicznych

Dr Gal Goldstein, wyróżniony na liście najlepszych lekarzy magazynu Forbes, kieruje Oddziałem Onkologii i Hemato-Onkologii Dziecięcej w Szpitalu Hadassah Ein Kerem.

• Ponad 20 lat specjalizacji w dziedzinie hemato-onkologii dziecięcej i haploidentycznego przeszczepu szpiku kostnego
• Członek wielu prestiżowych stowarzyszeń onkologicznych, w tym SIOP i ISPHO
• Koncentruje się na leczeniu siatkówczaka (retinoblastoma) oraz medycynie precyzyjnej w onkologii dziecięcej

Dr Alemdar specjalizuje się w onkologii medycznej, odbył szerokie szkolenie na Uniwersytecie Akdeniz, wiodącej instytucji w Turcji.

• Certyfikowany w zakresie onkologii medycznej od 2018 roku
• Ponad 15 lat doświadczenia w onkologii
• Pracuje w kompleksie szpitalnym Medical Park Antalya

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Specjalizuje się w nowotworach głowy i szyi oraz raku tarczycy, wykorzystując zaawansowane techniki radioterapii w Centrum Medycznym Hadassah.

• Odbył(a) szkolenie z radiochirurgii w Memorial Sloan Kettering Cancer Center
• Ponad 20 lat doświadczenia w onkologii i radioterapii
• Były Kierownik Oddziału Onkologii Głowy i Szyi w Davidoff Cancer Center
• Dyrektor Oddziału Onkologii w Hadassah od 2019 roku

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Specjalizuje się w robotycznie wspomaganej chirurgii serca – nowatorskim podejściu wykorzystującym precyzyjne, małoinwazyjne techniki.

• Ponad 25 lat doświadczenia w kardiochirurgii
• Ekspertyza w zakresie naprawy i wymiany zastawek
• Szkolenie odbyło się w University of California, San Diego
• Przeprowadza operacje kardiochirurgiczne u dzieci

Profesor Lim, Kierownik Oddziału Onkologii Radiacyjnej w Samsung Medical Center, specjalizuje się w złożonych przypadkach nowotworowych.

• Kształcił się w Kolegium Medycznym Narodowego Uniwersytetu Seulskiego
• Specjalizuje się w guzach żołądka, trzustkowo-żółciowych oraz OUN
• Leczy również nowotwory dziecięce i mięsaki
• Ukończył szkolenie specjalistyczne w Samsung Medical Center i Szpitalu Narodowego Uniwersytetu Seulskiego